Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

Keytruda is already widely prescribed by clinicians for newly-diagnosed NSCLC patients, as the drug has showed a clear benefit both as a monotherapy and in combination with chemotherapy. ... Merck’s position in the NSCLC market has fostered immense

NICE approves Roche’s Tecentriq in TNBC after revising deal

NICE approves Roche’s Tecentriq in TNBC after revising deal Merck &Co/MSD’s rival checkpoint inhibitor Keytruda (pembrolizumab) has not shown the same level of efficacy in TNBC, although it has shown promise when used prior to surgery in women

FDA gives Roche’s Tecentriq green light for first-line NSCLC

FDA gives Roche’s Tecentriq green light for first-line NSCLC Company enters lucrative and competitive market dominated by Merck/MSD’s rival Keytruda. ... application. At least in the US, BMS can now challenge Keytruda and newcomer Tecentriq, with a chemotherapy-limited option for patients with progressive NSCLC.

HTA guidance from NICE, the SMC and the AWMSG

NICE has said that the recently-approved combination of Merck &Co/MSD’s Keytruda with Pfizer’s Inlyta shouldn’t be. ... The Keytruda/Inlyta combination was approved by the EMA for. 5 Feb 2020.

AZ, Daiichi Sankyo’s Enhertu fast-tracked in US for NSCLC

AZ, Daiichi Sankyo’s Enhertu fast-tracked in US for NSCLC Now, AZ and Daiichi are looking to broaden Enhertu’s horizons, and encroach onto the highly competitive NSCLC market, which is otherwise dominated by Merck/MSD’s PD-1 inhibitor Keytruda ... pembrolizumab). Despite Keytruda’s dominance, the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...
ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...

Infographics